We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$6.39B
AUM Growth
+$1.46B
Cap. Flow
+$813M
Cap. Flow %
12.72%
Top 10 Hldgs %
30%
Holding
130
New
34
Increased
32
Reduced
37
Closed
15

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$114M
2
CNC icon
Centene
CNC
+$75.1M
3
ESPR
Esperion Therapeutics
ESPR
+$67.2M
4
SPOT icon
Spotify
SPOT
+$55.4M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$51.4M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$198M
2
MSFT icon
Microsoft
MSFT
+$102M
3
BAX icon
Baxter International
BAX
+$84.8M
4
MOH icon
Molina Healthcare
MOH
+$65.2M
5
UNH icon
UnitedHealth
UNH
+$50.1M

Sector Composition

Rank Sector Weight
1 Healthcare 48.69%
2 Technology 9.35%
3 Communication Services 7.21%
4 Consumer Discretionary 2.57%
5 Financials 2.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
51
CALL
Viatris
VTRS
$20.8B
$46M 0.72%
1,271,700
-105,200
-8% -$4.13M
TFX icon
52
Teleflex
TFX
$5.94B
$45.5M 0.71%
169,796
+2,045
+1% +$548K
BSX icon
53
Boston Scientific
BSX
$68.5B
$43.1M 0.67%
1,317,120
+597,818
+83% +$18M
ELGX
54
DELISTED
Endologix Inc
ELGX
$42.7M 0.67%
754,216
-20,077
-3% -$1.02M
PYPL icon
55
PayPal
PYPL
$51.4B
$42.6M 0.67%
511,754
-381,002
-43% -$30.4M
ATVI
56
DELISTED
Activision Blizzard
ATVI
$42.2M 0.66%
552,659
+12,405
+2% +$878K
ISRG icon
57
Intuitive Surgical
ISRG
$130B
$41.8M 0.65%
+261,981
New +$40M
EA icon
58
Electronic Arts
EA
$52.4B
$41.1M 0.64%
+291,101
New +$37.8M
SPGI icon
59
S&P Global
SPGI
$126B
$41M 0.64%
+201,114
New +$39.7M
CSII
60
DELISTED
Cardiovascular Systems, Inc.
CSII
$39.8M 0.62%
1,230,921
+409,767
+50% +$11.3M
IRTC icon
61
iRhythm Holdings
IRTC
$3.86B
$39.8M 0.62%
+490,430
New +$34.3M
TCOM icon
62
Trip.com Group
TCOM
$28.5B
$39.4M 0.62%
+826,224
New +$37.3M
CLVS
63
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$35.7M 0.56%
+784,700
New +$38.2M
ALDR
64
DELISTED
Alder Biopharmaceuticals
ALDR
$34.9M 0.55%
2,205,913
-290,914
-12% -$4.42M
COUP
65
DELISTED
Coupa Software Incorporated
COUP
$33.4M 0.52%
535,892
-12,479
-2% -$664K
XYZ
66
Block Inc
XYZ
$49.5B
$32.4M 0.51%
525,942
-369,449
-41% -$20.3M
APTX
67
DELISTED
Aptinyx Inc. Common Stock
APTX
$32.1M 0.5%
+1,379,916
New +$29.5M
MA icon
68
Mastercard
MA
$497B
$31M 0.49%
+157,764
New +$29.7M
NVDA icon
69
NVIDIA
NVDA
$4.77T
$30.7M 0.48%
5,186,160
+2,522,080
+95% +$15.3M
NFLX icon
70
Netflix
NFLX
$301B
$30.3M 0.47%
774,740
-21,170
-3% -$722K
DVA icon
71
CALL
DaVita
DVA
$15.4B
$29.2M 0.46%
+420,400
New +$28.1M
CRUS icon
72
Cirrus Logic
CRUS
$6.87B
$29M 0.45%
+756,546
New +$28.9M
BABA icon
73
CALL
Alibaba
BABA
$276B
$28.9M 0.45%
+156,000
New +$29.7M
GWRE icon
74
Guidewire Software
GWRE
$13.3B
$27M 0.42%
+304,256
New +$26.9M
PVTL
75
DELISTED
Pivotal Software, Inc.
PVTL
$23.8M 0.37%
+979,223
New +$20.2M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q2 2018 Portfolio in Review

As of Q2 2018, PFM Health Sciences held 130 positions worth $6.39B, up 30% from $4.92B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

PFM Health Sciences deployed $813M of net new capital in Q2 2018, opening 34 new positions and adding to 32 existing holdings. Its largest new stake was Clovis Oncology, Inc.: 2,337,225 shares worth $106M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 60% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Microsoft, an estimated $102M trimmed.

  • PFM Health Sciences's largest Q2 2018 buy was Clovis Oncology, Inc.: 2,337,225 shares worth $106M.
  • PFM Health Sciences added most to Esperion Therapeutics in Q2 2018, an estimated $67.2M increase.
  • PFM Health Sciences's biggest Q2 2018 reduction was Microsoft, cutting an estimated $102M.
  • PFM Health Sciences fully exited Bristol-Myers Squibb in Q2 2018, selling an estimated $198M.
  • PFM Health Sciences's ten largest holdings make up 30% of its $6.39B portfolio in Q2 2018.
  • PFM Health Sciences opened 34 new positions and closed 15 in Q2 2018.
  • PFM Health Sciences's portfolio value rose 30% quarter-over-quarter to $6.39B.

Based on PFM Health Sciences's 13F filing for Q2 2018, filed 14 Aug 2018.